A carregar...
Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer
Selective estrogen receptor downregulators (SERDs) are a novel class of compounds capable of reducing the ERα protein level and blocking ER activity. Therefore, SERDs are considered as a significant therapeutic approach to treat ER+ breast cancer in both early stage and more advanced drug-resistant...
Na minha lista:
| Publicado no: | RSC Med Chem |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Royal Society of Chemistry
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7580774/ https://ncbi.nlm.nih.gov/pubmed/33479648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9md00570f |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|